How Much Is Actually In The Vial
For laboratory research use only. Not for human or veterinary use.
A bigger number on the label is not always more compound, and it is not always the better vial. Four reasons, each of them checkable, and the cases where the big vial is right after all.
Research peptides are sold by the milligram, and the milligram figure is the first thing anyone compares. It is a reasonable thing to compare. It is just not the only thing that decides what you can actually get out of the vial and into an experiment — and on a couple of compounds it is not even telling you how much compound you bought.
We have a commercial interest here and it would be dishonest not to say so: we stock Glutathione in 400mg and 600mg and not the 1500mg most of the market sells. Read the last section before you decide how much weight to give the rest.
1. Solubility sets a ceiling, and the market ignores it
Every lyophilised compound has a concentration above which it will not readily go into aqueous solution. Glutathione is the clearest example in our catalogue. Cayman Chemical’s data sheet puts the aqueous solubility of reduced glutathione at about 20 mg/ml.
Reconstituted into the 2–3ml a vial of this size normally takes:
| Vial | In 3ml | Against 20 mg/ml | Volume for a true solution |
|---|---|---|---|
| 400mg | 133 mg/ml | 6.7× | 20 ml |
| 600mg | 200 mg/ml | 10× | 30 ml |
| 1500mg | 500 mg/ml | 25× | 75 ml |
Every size is past it, ours included. That is the nature of the material and nobody in this market pretends otherwise. But the distance matters: at 6.7× you are working with a supersaturated solution that behaves; at 25× you are working with one that takes a long time to go in, tends to leave undissolved material behind, and is markedly acidic — glutathione carries two carboxyl groups and a free thiol, and a heavily concentrated solution of it is nowhere near neutral.
The 1500mg vial wins a price-per-milligram comparison. Whether you can use all 1500mg is a separate question, and the answer depends on what volume your protocol will tolerate.
2. A milligram of salt is not a milligram of peptide
Most peptides are supplied as a salt, because the salt is the more stable solid. The salt weighs more than the peptide inside it. So a “10mg” vial can mean two quite different things depending on which one the supplier weighed.
| Compound | Free form | Salt | 10mg of salt contains |
|---|---|---|---|
| BPC-157 | 1419.55 (peptide) | 1593.74 (arginate) | 8.91 mg of peptide |
| GHK-Cu | 401.91 (complex) | 460.96 (acetate) | 8.72 mg of complex |
Eleven to thirteen per cent, on a figure nobody thinks to question. Two suppliers can both print “10mg” honestly and ship measurably different amounts of compound.
Our convention: the milligram figure on our labels refers to the peptide or complex, not the salt. It says so on both product pages. That is the more expensive convention and it is the one worth asking any supplier about — not because the other answer is dishonest, but because you cannot compare two vials until you know which question each of them answered.
The same arithmetic, worked through in more detail on a compound where it is even larger: the salt arithmetic and NNMT.
3. Purity is a percentage, not a quantity
A purity figure is the share of the total peak area belonging to the target compound. It says nothing about how much is in the vial. 99% of a bigger vial is not more compound than 99% of a smaller one — it is the same proportion of a different amount, and a purity figure attached to a vial nobody weighed tells you nothing at all about quantity.
This is why a certificate that reports quantity found alongside purity is worth more than one that reports purity alone, and why we publish both where the laboratory measured both. More on what a purity figure does and does not mean: HPLC purity testing explained.
4. Concentration decides how much you never get back
Put more compound in the same volume and every draw is more concentrated, which means every microlitre stranded in the syringe hub costs you more material. This is the entire reason low dead-space syringes exist. Our 1ml 30G is a B.Braun Omnican with 0.5 µl of dead volume, against several microlitres on a typical fixed-needle syringe.
At a dilute concentration that difference is trivial. At 500 mg/ml it is not. The bigger the vial, the more the equipment around it starts to matter — see syringes and needles for peptide research.
5. Bigger molecules are more fragile, not more robust
A five-residue peptide is a chain. An 83-residue protein has tertiary structure, and structure can be lost without a single bond breaking. IGF-1 LR3 is 83 residues and 9117.50 g/mol; it denatures with agitation, at surfaces and across freeze–thaw cycles in a way KPV at three residues simply does not.
So “more of it” also means more of something that is easier to damage before you use it. Aliquot rather than repeatedly thawing one vial, and swirl rather than shake — foaming is protein denaturing at the air–liquid interface, not a cosmetic problem.
When the bigger vial is the right one
All of the above is an argument for matching the vial to the protocol, not an argument that small is better. Bigger is genuinely better when:
- The compound is freely soluble at the concentration you need. Most short peptides are. The solubility ceiling is a real constraint on some compounds and a non-issue on others.
- You would otherwise be opening several vials. Every stopper pierced is a contamination opportunity and a handling step. One vial of 10mg is cleaner than five of 2mg.
- You are running a long series and the cost per milligram dominates. It usually is cheaper per milligram, and that is a legitimate reason to buy it.
- You have the volume. Most of the problems above disappear if you can reconstitute into more solvent. They only bite when the vial and the volume are fixed.
What we do about it, and where we benefit
Stated plainly, because a page like this from a supplier is worth nothing unless the conflict of interest is on it:
- We stock Glutathione at 400mg and 600mg and not 1500mg. The reasoning is section 1. We will source 1500mg on request — we just do not think it is the better vial.
- Our milligram figures refer to the peptide or complex, not the salt.
- We publish quantity found alongside purity where the laboratory measured both, in the COA library, with the issuing laboratory’s verification key on every one.
- We benefit from you believing section 1. Weigh it accordingly, and check the solubility figure yourself — it is on a manufacturer’s public data sheet, not ours.
The compounds this page uses as examples
Every figure above comes off one of these product pages or the certificate behind it. Check them rather than taking the argument on trust:
- Glutathione — the solubility ceiling — 400mg and 600mg, and why not 1500mg
- BPC-157 — arginine salt, 1593.74 against 1419.55 for the peptide
- GHK-Cu — acetate salt, 460.96 against 401.91 for the complex
- IGF-1 LR3 — 83 residues — a protein, and it behaves like one
- KPV — three residues, for contrast
- Insulin Syringes (1ml 30G) — 0.5 µl dead volume, which is the point of section 4
Pioneer Research Peptides — UK supplier of research peptides and laboratory solvents.
For laboratory research use only — not for human consumption. 18+.
Research-grade peptides, documented
Every Pioneer compound is Independently batch tested, with a batch-specific Certificate of Analysis available on request.
